Tus kws kho mob
QP33-25 Commercial Pharmacy Benefit Exclusion for Bkemv™, Otulfi™, Pyzchiva®, Selarsdi™ and Ustekinumab-ttwe™
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 09, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3131 - 3140 ntawm 4179
Tus kws kho mob
QP32-25 Cotiviti to Begin Preventable Readmission Audits
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 09, 2025
Tus kws kho mob
QP31-25 Peer-to-Peer Discussions for Denied Claims Ending
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 09, 2025
Tus kws kho mob
2025 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P30-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025